SPC Logo

White Liniment BP (White Embrocation BP)

Last Updated on eMC 22-Nov-2011 View changes  | Thornton & Ross Ltd Contact details

Discontinued Items

The preparations being discontinued are:

  • White liniment (Thornton & Ross Ltd)

The pharmaceutical company has decided to discontinue the product and so it may not be available in the future.  This document has been left on the eMC for information purposes.

1. Name of the medicinal product

White Liniment BP (White Embrocation BP)

2. Qualitative and quantitative composition

Turpentine Oil BP 25.0% v/v

3. Pharmaceutical form


4. Clinical particulars
4.1 Therapeutic indications

For relief of rheumatism, lumbago, sciatica and sprains.

4.2 Posology and method of administration

Applied directly to the skin.

Apply 2 or 3 times a day, as required. Rub thoroughly into the affected parts.

This product is suitable for use by adults and the elderly but is not recommended for children under 12 years, except under a doctor's instruction.

4.3 Contraindications

Sensitivity to turpentine oil

4.4 Special warnings and precautions for use

For external use only.

Avoid broken or inflamed skin.

Keep all medicines away from children.

Keep away from the eyes and other sensitive areas.

If symptoms persist seek medical advice.

4.5 Interaction with other medicinal products and other forms of interaction

None known.

4.6 Pregnancy and lactation

Use of all medicines should be avoided if possible during pregnancy and lactation. No information is available regarding safety of use of this product in the above condition.

4.7 Effects on ability to drive and use machines

None known.

4.8 Undesirable effects

May cause irritation. Absorption of large amounts may cause some of the effects of poisoning with turpentine oil.

4.9 Overdose

In case of accidental ingestion the symptoms will be those of turpentine poisoning, local burning and gastro-intestinal upset, coughing and choking, pulmonary oedema, excitement, coma, fever, tachycardia, liver damage, haematuria and albuminuria.

15ml of turpentine oil may be fatal to children (equivalent to 60ml of white liniment).

The stomach should be emptied by emesis or by aspiration and lavage. Suitable supportive measures should be taken.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Turpentine is applied externally in liniments as a counter-irritant and rubefacient.

5.2 Pharmacokinetic properties

No information available.

5.3 Preclinical safety data


6. Pharmaceutical particulars
6.1 List of excipients

Oleic Acid BP, Ammonium Chloride BP, Ammonia Solution Strong BP, Purified Water BP.

6.2 Incompatibilities

None known.

6.3 Shelf life


36 months


36 months

6.4 Special precautions for storage

Store below 25°C.

Do not allow to freeze.

6.5 Nature and contents of container

200ml Plain round amber glass bottle with plastic cap or white 28mm cap with tamper evident band and EPE Saranex liner.

500ml Amber glass winchester bottle with plastic cap or white 28mm cap with tamper evident band and EPE Saranex liner.

6.6 Special precautions for disposal and other handling

No special requirements.

7. Marketing authorisation holder

Thornton and Ross Limited

Linthwaite Laboratories



8. Marketing authorisation number(s)

PL 00240/6440R

9. Date of first authorisation/renewal of the authorisation

18th May 1998

10. Date of revision of the text


11 Dosimetry (if applicable)

Not Applicable

12 Instructions for preparation of radiopharmaceuticals (if applicable)

Not Applicable

Company contact details

Thornton & Ross Ltd

Company image

Linthwaite, Huddersfield , West Yorks, HD7 5QH

Medical Information e-mail
Medical Information Direct Line

0870 851 0207

Customer Care direct line

+44(0)1484 848200

Out of Hours Telephone

0870 851 0207

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

turpentine oil

Legal categories

GSL - General Sales List

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue